Deutsche Bank
ONCY

Deutsche Bank’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Deutsche Bank’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-43,200
Closed -$21K – 5540
2015
Q2 		$21K Buy
43,200
+41,200
+2,060% +$28K ﹤0.01% 4897
2015
Q1 		$1K Buy
2,000
+1,500
+300% +$963 ﹤0.01% 5065
2014
Q4 		$0 Buy
+500
New +$302 ﹤0.01% 6520
2014
Q3 		– Sell
-24,500
Closed -$31K – 6314
2014
Q2 		$31K Buy
24,500
+18,100
+283% +$25.9K ﹤0.01% 5150
2014
Q1 		$11K Buy
6,400
+1,800
+39% +$3.04K ﹤0.01% 5023
2013
Q4 		$7K Buy
4,600
+4,500
+4,500% +$10.1K ﹤0.01% 4982
2013
Q3 		$0 Sell
100
-300
-75% -$830 ﹤0.01% 5906
2013
Q2 		$1K Buy
+400
New +$1.11K ﹤0.01% 5324

Other funds holding ONCY

VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Deutsche Bank's ONCY Position: Q3 2015 in Review

Deutsche Bank sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q3 2015, closing a stake of 43,200 shares — an estimated $21K sold.

Deutsche Bank first reported a position in ONCY in Q2 2013 and held it in 8 quarters. The position peaked at $31K in Q2 2014. 27 funds tracked by Wall St. Rank hold ONCY as of Q3 2015.

  • Deutsche Bank reported no remaining ONCOLYTICS BIOTECH INC position as of Q3 2015 after selling out during the quarter.
  • Deutsche Bank sold 43,200 ONCOLYTICS BIOTECH INC shares in Q3 2015, an estimated $21K.
  • Deutsche Bank first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 8 quarters.
  • Deutsche Bank's ONCOLYTICS BIOTECH INC position peaked at $31K in Q2 2014.
  • 27 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2015.

Based on Deutsche Bank's 13F filing for Q3 2015, filed 17 Nov 2015.